Raymond Lai

Affiliations: 
Laboratory Medicine and Pathology University of Alberta, Edmonton, Alberta, Canada 
Area:
Oncology, Molecular Biology
Google:
"Raymond Lai"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lai J, Yang C, Shang C, et al. (2024) ULK2 Is a Key Pro-Autophagy Protein That Contributes to the High Chemoresistance and Disease Relapse in FLT3-Mutated Acute Myeloid Leukemia. International Journal of Molecular Sciences. 25
Lai J, Shang C, Chen W, et al. (2023) An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter. International Journal of Molecular Sciences. 25
Shang C, Lai J, Haque M, et al. (2023) Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma. International Journal of Molecular Sciences. 24
Jafari S, Heydarian S, Lai R, et al. (2022) Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. Bioimpacts : Bi. 13: 51-61
Garland GD, Ducray SP, Jahangiri L, et al. (2021) BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL. Cancers. 14
Li J, Haque M, Shang C, et al. (2021) Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter. Current Issues in Molecular Biology. 43: 543-557
Alshareef A, Peters AC, Gélébart P, et al. (2021) Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma. International Journal of Molecular Sciences. 22
Shang C, Hassan B, Haque M, et al. (2021) Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent. Cancers. 13
Haque M, Li J, Huang YH, et al. (2019) NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers. 11
Mackey JR, Beauchamp E, Yap MC, et al. (2019) Abstract 3046: Targeting N-myristoylation in B cell lymphomas as a therapeutic strategy Cancer Research. 79: 3046-3046
See more...